Dare Bioscience, Inc. - DARE
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$2.726M
QoQ value delta ($000)
-$13K
(-0.47%)
Implied price effect (QoQ)
-0.47%
Shares
Total shares
1,301,712
QoQ shares delta
-42
(-0.0%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (DARE)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 3 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1,352 | 640,877 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 295 | 140,093 | 0.0% |
| US BANCORP \DE\ | 255 | 120,920 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 192 | 91,269 | 0.0% |
| BlackRock, Inc. | 135 | 64,248 | 0.0% |
| STATE STREET CORP | 100 | 47,415 | 0.0% |
| JANE STREET GROUP, LLC | 76 | 36,092 | 0.0% |
| NORTHERN TRUST CORP | 72 | 34,209 | 0.0% |
| HRT FINANCIAL LP | 47 | 22,430 | 0.0% |
| Virtu Financial LLC | 33 | 15,803 | 0.0% |
| RAYMOND JAMES FINANCIAL INC | 31 | 14,864 | 0.0% |
| LPL Financial LLC | 31 | 14,889 | 0.0% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 29 | 13,318 | 0.0% |
| StoneX Group Inc. | 24 | 11,153 | 0.0% |
| Objectivity Squared, LLC | 23 | 10,915 | 0.01% |
| UBS Group AG | 14 | 6,810 | 0.0% |
| Farther Finance Advisors, LLC | 8 | 9,408 | 0.0% |
| Vanguard Global Advisers, LLC | 6 | 2,940 | 0.0% |
| Bay Harbor Wealth Management, LLC | 2 | 1,358 | 0.0% |
| SBI Securities Co., Ltd. | 1 | 645 | 0.0% |
| WELLS FARGO & COMPANY/MN | 0 | 0 | 0.0% |
| BARCLAYS PLC | 0 | 248 | 0.0% |
| CALDWELL SUTTER CAPITAL, INC. | 0 | 100 | 0.0% |
| JONES FINANCIAL COMPANIES LLLP | 0 | 396 | 0.0% |
| MATHER GROUP, LLC. | 0 | 84 | 0.0% |